Agile Therapeutics, Inc. provided revenue guidance for the First quarter 2023. For the period, the Company expects net revenue is expected to be in the range of $3.8 to $4.0 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.3749 USD | -2.37% | -6.16% | -80.77% |
May. 15 | Earnings Flash (AGRX) AGILE THERAPEUTICS Posts Q1 Revenue $5.7M | MT |
Mar. 28 | Transcript : Agile Therapeutics, Inc., Q4 2023 Earnings Call, Mar 28, 2024 |
1st Jan change | Capi. | |
---|---|---|
-80.77% | 2.63M | |
+10.79% | 115B | |
+11.65% | 106B | |
-6.20% | 24.69B | |
-2.33% | 21.97B | |
-6.03% | 19.27B | |
-13.41% | 17.56B | |
-40.50% | 17.32B | |
+6.64% | 14.03B | |
+31.84% | 12.13B |
- Stock Market
- Equities
- AGRX Stock
- News Agile Therapeutics, Inc.
- Agile Therapeutics, Inc. Provides Revenue Guidance for the First Quarter 2023